Walgreens to Follow CVS and Begin Selling CBD Products in Some Stores

Walgreens to Follow CVS and Begin Selling CBD Products in Some Stores

Walgreens will sell CBD products in Oregon, Colorado, New Mexico, Kentucky, Tennessee, Vermont, South Carolina, Illinois and Indiana.

Seth Rogen Partners With Canopy Growth to Get You to Love Recreational Weed

Seth Rogen Partners With Canopy Growth to Get You to Love Recreational Weed

Seth Rogen is an actor and avid cannabis smoker and his Houseplant brand is a partnership with Canopy Growth.

Cronos Cracks After Canaccord Downgrade and Bearish Canadian Adult-Use Outlook

Cronos Cracks After Canaccord Downgrade and Bearish Canadian Adult-Use Outlook

Analysts at Canaccord downgrade the company's Canadian-traded stock to sell while maintaining a C$17 price target.

Revenue at Cronos Rises but Its Losses Widen in 2018

Revenue at Cronos Rises but Its Losses Widen in 2018

Cronos shares fall sharply after the cannabis company swings to a loss in the fiscal year.

Cronos Group Certainly Qualifies for Mainstream Consideration

Cronos Group Certainly Qualifies for Mainstream Consideration

Revenue is where it's at for cannabis in 2019.

2 Big Earnings Reports I'll Be Watching This Week

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

7 Indirect Stock Plays on the Cannabis Sector

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

MedMen Secures $250 Million Investment From Gotham Green Partners

MedMen Secures $250 Million Investment From Gotham Green Partners

The investment in cannabis company MedMen is in the form of a senior secured convertible credit facility.

Curaleaf Says Hemp Products to Be Sold at CVS Stores

Curaleaf Says Hemp Products to Be Sold at CVS Stores

Curaleaf says it signed a deal with CVS to begin selling hemp products at 800 stores in 10 states.

Plus Cannabis Gummies Get a 'Speculative Buy' Rating With a Delicious Outlook

Plus Cannabis Gummies Get a 'Speculative Buy' Rating With a Delicious Outlook

If Plus cannabis gummies are a big hit, just think how consumers will respond to hemp-derived CBD gummies.